Two Sigma Securities’s Revance Therapeutics, Inc. RVNC Stock Holding History

Two Sigma Securities’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,657	Closed	-$35.4K	–	2383
2024 Q4	$35.4K	Buy	+11,657	New	+$50.8K	﹤0.01%	1228

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Securities's RVNC Position: Q1 2025 in Review

Two Sigma Securities sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 11,657 shares — an estimated $35.4K sold.

Two Sigma Securities first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $35.4K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Two Sigma Securities reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 11,657 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $35.4K.
Two Sigma Securities first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
Two Sigma Securities's Revance Therapeutics, Inc. position peaked at $35.4K in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.